Atlanta, GA - September 23, 2017

(Winship Cancer Institute at Emory University)

Date: Saturday – September 23, 2017
Time:  7:30am – 12:00pm EDT
Location:
Kaufmann Auditorium, 5th Floor
Building C
1365 Clifton Rd.
Atlanta, GA  30322

Free valet parking at Winship (Building C)

Individuals can attend in-person or watch via live stream. Registration is below.

Presenters and Topics

TimeAgenda

7:30am

Registration

8:15am

Opening Remarks

8:20am

Prevention/Early Detection
Suephy Chen, MD
Professor and Vice Chair, Department of Dermatology at Emory University School of Medicine
Director, Cutaneous Melanoma and Pigmented Lesion Clinics at Winship Cancer Institute of Emory University

8:40am

Lymph Node Dissection for Melanoma – How to prevent complications? Do you need a LND?
Keith Delman, MD
Co-Chair, Melanoma Working Group at Winship Cancer Institute of Emory University

9:00am

Complications of Immunotherapy
Ragi Kudchadkar, MD
Associate Professor, Department of Hematology and Medical Oncology at Emory University School of Medicine

9:20am

Introduction to Clinical Trials
Ragi Kudchadkar, MD
Associate Professor, Department of Hematology and Medical Oncology at Emory University School of Medicine

9:40am

BRAF mutation – What does it mean? What are the complications of BRAF inhibitors?
Melinda Yushak, MD
Assistant Professor, Department of Hematology and Medical Oncology at Emory University School of Medicine

10:00am

Break

10:15am

Integrative Medicine
Maggie Diller, MD
Surgical Resident at Winship Cancer Institute of Emory University

10:30am

Diet and Cancer
Tiffany Barrett, MS, RD, CSO, LD
Manager of Winship Dietitians at Winship Cancer Institute of Emory University

10:50am

Financial Implications of Cancer
Melissa Childress, MBA
Vice President of Cancer Services at Winship Cancer Institute of Emory University

11:10am

Patient Panel

11:40am

Questions & Answers

Other Information

Bagels and coffee will be provided.
If you have any questions, please email sguild@AIMatMelanoma.org

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.